Furthermore, protein kinase RIPK4 promotes the invasiveness of bladder urothelial carcinoma (Liu et al., 2018) and pancreatic cancer (Qi et al., 2018) through nuclear factor‐κB pathway and RAF1/MEK/ERK pathway, respectively. Here, RIPK4 is linked to bladder transitional cell carcinoma.